Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
276 studies found for:    Cerebral Atrophy
Show Display Options
Rank Status Study
1 Completed
Has Results
A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease
Condition: Alzheimer's Disease
Interventions: Drug: Memantine;   Drug: Placebo
2 Completed Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
Conditions: Alzheimer's Disease;   Posterior Cortical Atrophy;   Logopenic Progressive Aphasia
3 Recruiting Comparison of Brain Atrophy Rates, Cognition, and Patient-Reported Outcomes in MS Patients Using Long-term Fingolimod and Glatiramer Acetate
Condition: Multiple Sclerosis
4 Recruiting Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)?
Condition: Multiple Sclerosis
5 Completed Sunphenon in Progressive Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Sunphenon EGCG;   Drug: Placebo
6 Completed Focal Cortical Atrophy After Myocardial Internal Capsule
Condition: Ischemic Stroke Involving Corticospinal Tract.
Intervention: Other: Additional MRI
7 Completed A Longitudinal Study of Brain Atrophy in MS Patients Over 5 Years
Condition: Multiple Sclerosis
8 Completed Evaluation of Brain Atrophy in CIS Patients on Avonex
Condition: Multiple Sclerosis
9 Recruiting Effect of Fingolimod on Neurodegeneration
Conditions: Cognition,;   Brain Volume Loss
Intervention: Drug: 0,5 mg Fingolimod
10 Recruiting Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition
Condition: Cognitive Decline
11 Recruiting Structural and Functional Brain Reorganization in Neuropathic Pain. Influences of the Loss of Sensitivity and the Atrophy Cortical on Activations Due to Stimulation Allodynic
Condition: Neuropathic Pain
Interventions: Other: stimulation on painful area (area allodynic);   Other: same stimulation on non-painful area;   Radiation: MRI scan
12 Not yet recruiting Molecular and Structural Imaging in Atypical Alzheimer's Disease: A Longitudinal Study
Conditions: Atypical Alzheimer's Disease;   Logopenic Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
Interventions: Drug: F-18 AV 1451;   Drug: C-11 PiB
13 Active, not recruiting Study of Tcelna (Imilecleucel-T) in Secondary Progressive Multiple Sclerosis
Conditions: Autoimmune Diseases of the Nervous System;   Multiple Sclerosis;   Secondary Progressive Multiple Sclerosis;   Disease Progression;   Brain Atrophy
Interventions: Biological: Tcelna;   Biological: Placebo
14 Recruiting Aerobic Exercise and Brain Health in Multiple Sclerosis
Conditions: Multiple Sclerosis;   Brain Atrophy;   Cognitive Impairment
Intervention: Other: Aerobic exercise
15 Active, not recruiting Tau Imaging in Young Onset Dementia
Conditions: Alzheimer's Disease, Early Onset;   Logopenic Progressive Aphasia;   Posterior Cortical Atrophy (PCA)
Intervention: Drug: [18F]-T807 imaging tracer
16 Completed Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Drug: Simvastatin;   Drug: Placebo
17 Completed Gait and Alzheimer Interaction Tracking (GAIT) Study
Conditions: Gait Apraxia;   Alzheimer Disease;   Impaired Cognition;   Cerebral Atrophy
18 Completed Fingolimod Versus Interferon Beta 1b in Cognitive Symptoms
Condition: Multiple Sclerosis
Interventions: Drug: Fingolimod;   Drug: Interferon beta 1b
19 Withdrawn Safety and Brain Protection Effects of the Green Tea Extract Theaphenon 95% (95% Pure EGCG) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: 95% Pure ECGC capsules 200mg;   Drug: Placebo Comparator:
20 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years